KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Current Leases (2019 - 2025)

Historic Current Leases for West Pharmaceutical Services (WST) over the last 7 years, with Q4 2025 value amounting to $22.7 million.

  • West Pharmaceutical Services' Current Leases rose 2681.56% to $22.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $22.7 million, marking a year-over-year increase of 2681.56%. This contributed to the annual value of $22.7 million for FY2025, which is 2681.56% up from last year.
  • According to the latest figures from Q4 2025, West Pharmaceutical Services' Current Leases is $22.7 million, which was up 2681.56% from $21.4 million recorded in Q3 2025.
  • Over the past 5 years, West Pharmaceutical Services' Current Leases peaked at $22.7 million during Q4 2025, and registered a low of $8.1 million during Q3 2021.
  • Moreover, its 5-year median value for Current Leases was $16.3 million (2023), whereas its average is $15.8 million.
  • Per our database at Business Quant, West Pharmaceutical Services' Current Leases crashed by 1818.18% in 2021 and then skyrocketed by 7204.3% in 2022.
  • Over the past 5 years, West Pharmaceutical Services' Current Leases (Quarter) stood at $9.3 million in 2021, then skyrocketed by 72.04% to $16.0 million in 2022, then rose by 10.62% to $17.7 million in 2023, then grew by 1.13% to $17.9 million in 2024, then rose by 26.82% to $22.7 million in 2025.
  • Its Current Leases was $22.7 million in Q4 2025, compared to $21.4 million in Q3 2025 and $20.9 million in Q2 2025.